Literature DB >> 15702130

Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland.

Anna Dubaniewicz1, Sarra E Jamieson, M Dubaniewicz-Wybieralska, Michaela Fakiola, E Nancy Miller, Jenefer M Blackwell.   

Abstract

Sarcoidosis (SA) is a systemic granulomatous disorder of unknown etiology characterized by T helper 1-type inflammatory responses at sites of disease with signs of B cell hyperactivity. Like rheumatoid arthritis and diabetes, an infectious etiology has frequently been postulated but no single infectious trigger definitively identified. Polymorphic alleles at SLC11A1 have previously been associated with susceptibility to both the putative infectious agents and to these autoimmune disorders. We therefore investigated its candidacy as a genetic determinant of SA in Poland in an association-based study comparing 86 SA patients with 85 tuberculosis (TB) patients and 93 control subjects. The functional promoter (GT)(n) polymorphism and four of 10 other single nucleotide or insertion/deletion polymorphisms genotyped across SLC11A1 were informative in our sample. Consistent with previous autoimmune disease studies, allele 3 at the functional (GT)(n) promoter region repeat polymorphism was significantly associated with SA when compared with healthy controls (odds ratio 1.68; 95% CI: 1.01-2.81; P=0.04) or with TB patients (odds ratio 1.69; 95% CI: 1.042-0.78; P=0.03).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15702130     DOI: 10.1038/sj.ejhg.5201370

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  17 in total

1.  The functional SLC11A1 gene polymorphisms are associated with sarcoidosis in Turkish population.

Authors:  Pinar Akçakaya; Benura Azeroglu; Ipek Even; Omer Ates; Hatice Turker; Gul Ongen; Aysegul Topal-Sarikaya
Journal:  Mol Biol Rep       Date:  2011-12-08       Impact factor: 2.316

Review 2.  Genetics of sarcoidosis: candidate genes and genome scans.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Proc Am Thorac Soc       Date:  2007-01

3.  Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis.

Authors:  Anna Dubaniewicz; Miroslawa Dubaniewicz-Wybieralska; Adam Sternau; Zofia Zwolska; Ewa Izycka-Swieszewska; Ewa Augustynowicz-Kopec; Jaroslaw Skokowski; Mahavir Singh; Lech Zimnoch
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

4.  Glomerulonephritis in sarcoidosis.

Authors:  Hiroyuki Morita; Ashio Yoshimura
Journal:  Clin Exp Nephrol       Date:  2006-03       Impact factor: 2.801

Review 5.  Gene-environment interactions in sarcoidosis: challenge and opportunity.

Authors:  Daniel A Culver; Lee S Newman; Mani S Kavuru
Journal:  Clin Dermatol       Date:  2007 May-Jun       Impact factor: 3.541

6.  Diminished Susceptibility of African-Americans to Non-tuberculous Mycobacterial Disease.

Authors:  Jerome M Reich; Jong S Kim
Journal:  Lung       Date:  2017-11-13       Impact factor: 2.584

Review 7.  Tuberculosis as a complex trait: impact of genetic epidemiological study design.

Authors:  Catherine M Stein; Allison R Baker
Journal:  Mamm Genome       Date:  2010-11-23       Impact factor: 2.957

8.  Genomics of human pulmonary tuberculosis: from genes to pathways.

Authors:  Catherine M Stein; Lindsay Sausville; Christian Wejse; Rafal S Sobota; Nicola M Zetola; Philip C Hill; W Henry Boom; William K Scott; Giorgio Sirugo; Scott M Williams
Journal:  Curr Genet Med Rep       Date:  2017-10-12

9.  M. paratuberculosis Heat Shock Protein 65 and Human Diseases: Bridging Infection and Autoimmunity.

Authors:  Coad Thomas Dow
Journal:  Autoimmune Dis       Date:  2012-09-29

10.  Nuclear translocation of beta-actin is involved in transcriptional regulation during macrophage differentiation of HL-60 cells.

Authors:  Yong Zhong Xu; Thusanth Thuraisingam; David Anderson de Lima Morais; Marek Rola-Pleszczynski; Danuta Radzioch
Journal:  Mol Biol Cell       Date:  2010-01-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.